| Literature DB >> 31410392 |
Elizabeth J Hennessy1, Coen van Solingen1, Kaitlyn R Scacalossi1, Mireille Ouimet1, Milessa S Afonso1, Jurrien Prins2, Graeme J Koelwyn1, Monika Sharma1, Bhama Ramkhelawon1, Susan Carpenter3, Albert Busch4,5, Ekaterina Chernogubova4, Ljubica Perisic Matic4, Ulf Hedin4, Lars Maegdefessel4,5, Brian E Caffrey6, Maryem A Hussein7, Emiliano P Ricci8, Ryan E Temel9, Michael J Garabedian7, Jeffrey S Berger1, Kasey C Vickers10, Matthew Kanke11, Praveen Sethupathy11, Daniel Teupser12, Lesca M Holdt12, Kathryn J Moore1.
Abstract
The human genome encodes thousands of long non-coding RNAs (lncRNAs), the majority of which are poorly conserved and uncharacterized. Here we identify a primate-specific lncRNA (CHROME), elevated in the plasma and atherosclerotic plaques of individuals with coronary artery disease, that regulates cellular and systemic cholesterol homeostasis. LncRNA CHROME expression is influenced by dietary and cellular cholesterol via the sterol-activated liver X receptor transcription factors, which control genes mediating responses to cholesterol overload. Using gain- and loss-of-function approaches, we show that CHROME promotes cholesterol efflux and HDL biogenesis by curbing the actions of a set of functionally related microRNAs that repress genes in those pathways. CHROME knockdown in human hepatocytes and macrophages increases levels of miR-27b, miR-33a, miR-33b and miR-128, thereby reducing expression of their overlapping target gene networks and associated biologic functions. In particular, cells lacking CHROME show reduced expression of ABCA1, which regulates cholesterol efflux and nascent HDL particle formation. Collectively, our findings identify CHROME as a central component of the non-coding RNA circuitry controlling cholesterol homeostasis in humans.Entities:
Year: 2018 PMID: 31410392 PMCID: PMC6691505 DOI: 10.1038/s42255-018-0004-9
Source DB: PubMed Journal: Nat Metab ISSN: 2522-5812